AKR1B1 and ovarian cancer: In our study, elevated levels of AKR1B1 and ALDH5A1 in post-NACT treated tumors suggests alterations in proteins regulating cellular metabolism accompanies exposure of ovarian cancer cells to cytotoxic chemotherapy.